ID C1RA_MOUSE Reviewed; 707 AA. AC Q8CG16; Q99KI6; Q9ET60; DT 24-MAY-2004, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2003, sequence version 1. DT 24-JAN-2024, entry version 167. DE RecName: Full=Complement C1r-A subcomponent; DE EC=3.4.21.41; DE AltName: Full=Complement component 1 subcomponent r-A; DE Contains: DE RecName: Full=Complement C1r-A subcomponent heavy chain; DE Contains: DE RecName: Full=Complement C1r-A subcomponent light chain; DE Flags: Precursor; GN Name=C1ra; Synonyms=C1r; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=C57BL/6J; RA Byun S.J., Hyun J.H., Hwang H.Y., Ryoo Z.Y., Kim T.Y.; RT "Cloning and sequencing of a cDNA encoding a serine protease homologous to RT human complement C1r precursor from an allografted mouse skin and its RT expression in Escherichia coli."; RL Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY. RC STRAIN=129/SvJ; RX PubMed=12513694; DOI=10.1042/bj20021555; RA Garnier G., Circolo A., Xu Y., Volanakis J.E.; RT "Complement C1r and C1s genes are duplicated in the mouse: differential RT expression generates alternative isomorphs in the liver and in the male RT reproductive system."; RL Biochem. J. 371:631-640(2003). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-220. RC STRAIN=C57BL/6J; TISSUE=Plasma; RX PubMed=17330941; DOI=10.1021/pr0604559; RA Bernhard O.K., Kapp E.A., Simpson R.J.; RT "Enhanced analysis of the mouse plasma proteome using cysteine-containing RT tryptic glycopeptides."; RL J. Proteome Res. 6:987-995(2007). CC -!- FUNCTION: C1r B chain is a serine protease that combines with C1q and CC C1s to form C1, the first component of the classical pathway of the CC complement system. CC -!- CATALYTIC ACTIVITY: CC Reaction=Selective cleavage of Lys(or Arg)-|-Ile bond in complement CC subcomponent C1s to form the active form of C1s (EC 3.4.21.42).; CC EC=3.4.21.41; CC -!- SUBUNIT: C1 is a calcium-dependent trimolecular complex of C1q, C1r and CC C1s in the molar ration of 1:2:2. C1r is a dimer of identical chains, CC each of which is activated by cleavage into two chains, A and B, CC connected by disulfide bonds (By similarity). {ECO:0000250}. CC -!- PTM: The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate CC and asparagine is (R) stereospecific within EGF domains. {ECO:0000250}. CC -!- SIMILARITY: Belongs to the peptidase S1 family. {ECO:0000255|PROSITE- CC ProRule:PRU00274}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF148216; AAG01898.1; -; mRNA. DR EMBL; AF459011; AAO15553.1; -; Genomic_DNA. DR EMBL; AF459008; AAO15553.1; JOINED; Genomic_DNA. DR EMBL; AF459009; AAO15553.1; JOINED; Genomic_DNA. DR EMBL; AF459010; AAO15553.1; JOINED; Genomic_DNA. DR EMBL; BC004637; AAH04637.1; -; mRNA. DR CCDS; CCDS20521.1; -. DR RefSeq; NP_075632.3; NM_023143.3. DR AlphaFoldDB; Q8CG16; -. DR SMR; Q8CG16; -. DR ComplexPortal; CPX-4984; Complement C1 complex, C1ra-C1sa variant. DR STRING; 10090.ENSMUSP00000063707; -. DR MEROPS; S01.209; -. DR GlyCosmos; Q8CG16; 3 sites, No reported glycans. DR GlyGen; Q8CG16; 3 sites. DR iPTMnet; Q8CG16; -. DR PhosphoSitePlus; Q8CG16; -. DR MaxQB; Q8CG16; -. DR PaxDb; 10090-ENSMUSP00000063707; -. DR PeptideAtlas; Q8CG16; -. DR ProteomicsDB; 265402; -. DR Pumba; Q8CG16; -. DR DNASU; 50909; -. DR Ensembl; ENSMUST00000068593.9; ENSMUSP00000063707.8; ENSMUSG00000055172.11. DR GeneID; 50909; -. DR KEGG; mmu:50909; -. DR UCSC; uc009dra.2; mouse. DR AGR; MGI:1355313; -. DR CTD; 50909; -. DR MGI; MGI:1355313; C1ra. DR VEuPathDB; HostDB:ENSMUSG00000055172; -. DR eggNOG; KOG3627; Eukaryota. DR GeneTree; ENSGT00940000158621; -. DR HOGENOM; CLU_006842_14_1_1; -. DR InParanoid; Q8CG16; -. DR OMA; RIPACLP; -. DR OrthoDB; 5394076at2759; -. DR PhylomeDB; Q8CG16; -. DR TreeFam; TF330373; -. DR Reactome; R-MMU-166663; Initial triggering of complement. DR Reactome; R-MMU-173623; Classical antibody-mediated complement activation. DR Reactome; R-MMU-977606; Regulation of Complement cascade. DR BioGRID-ORCS; 50909; 2 hits in 77 CRISPR screens. DR ChiTaRS; C1ra; mouse. DR PRO; PR:Q8CG16; -. DR Proteomes; UP000000589; Chromosome 6. DR RNAct; Q8CG16; Protein. DR Bgee; ENSMUSG00000055172; Expressed in mesenteric lymph node and 97 other cell types or tissues. DR GO; GO:0005615; C:extracellular space; ISO:MGI. DR GO; GO:0005509; F:calcium ion binding; ISO:MGI. DR GO; GO:0042802; F:identical protein binding; ISO:MGI. DR GO; GO:0140313; F:molecular sequestering activity; ISO:MGI. DR GO; GO:0004252; F:serine-type endopeptidase activity; ISO:MGI. DR GO; GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW. DR GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW. DR GO; GO:0031638; P:zymogen activation; ISO:MGI. DR CDD; cd00033; CCP; 2. DR CDD; cd00041; CUB; 2. DR CDD; cd00054; EGF_CA; 1. DR CDD; cd00190; Tryp_SPc; 1. DR Gene3D; 2.10.70.10; Complement Module, domain 1; 2. DR Gene3D; 2.10.25.10; Laminin; 1. DR Gene3D; 2.60.120.290; Spermadhesin, CUB domain; 2. DR Gene3D; 2.40.10.10; Trypsin-like serine proteases; 1. DR InterPro; IPR000859; CUB_dom. DR InterPro; IPR001881; EGF-like_Ca-bd_dom. DR InterPro; IPR000742; EGF-like_dom. DR InterPro; IPR018097; EGF_Ca-bd_CS. DR InterPro; IPR024175; Pept_S1A_C1r/C1S/mannan-bd. DR InterPro; IPR009003; Peptidase_S1_PA. DR InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin. DR InterPro; IPR001314; Peptidase_S1A. DR InterPro; IPR035914; Sperma_CUB_dom_sf. DR InterPro; IPR035976; Sushi/SCR/CCP_sf. DR InterPro; IPR000436; Sushi_SCR_CCP_dom. DR InterPro; IPR001254; Trypsin_dom. DR InterPro; IPR033116; TRYPSIN_SER. DR PANTHER; PTHR24255:SF25; COMPLEMENT C1R SUBCOMPONENT; 1. DR PANTHER; PTHR24255; COMPLEMENT COMPONENT 1, S SUBCOMPONENT-RELATED; 1. DR Pfam; PF00431; CUB; 2. DR Pfam; PF14670; FXa_inhibition; 1. DR Pfam; PF00084; Sushi; 2. DR Pfam; PF00089; Trypsin; 1. DR PIRSF; PIRSF001155; C1r_C1s_MASP; 1. DR PRINTS; PR00722; CHYMOTRYPSIN. DR SMART; SM00032; CCP; 2. DR SMART; SM00042; CUB; 2. DR SMART; SM00181; EGF; 1. DR SMART; SM00179; EGF_CA; 1. DR SMART; SM00020; Tryp_SPc; 1. DR SUPFAM; SSF57535; Complement control module/SCR domain; 2. DR SUPFAM; SSF57196; EGF/Laminin; 1. DR SUPFAM; SSF49854; Spermadhesin, CUB domain; 2. DR SUPFAM; SSF50494; Trypsin-like serine proteases; 1. DR PROSITE; PS00010; ASX_HYDROXYL; 1. DR PROSITE; PS01180; CUB; 2. DR PROSITE; PS01186; EGF_2; 1. DR PROSITE; PS01187; EGF_CA; 1. DR PROSITE; PS50923; SUSHI; 2. DR PROSITE; PS50240; TRYPSIN_DOM; 1. DR PROSITE; PS00135; TRYPSIN_SER; 1. DR Genevisible; Q8CG16; MM. PE 1: Evidence at protein level; KW Complement pathway; Disulfide bond; EGF-like domain; Glycoprotein; KW Hydrolase; Hydroxylation; Immunity; Innate immunity; Phosphoprotein; KW Protease; Reference proteome; Repeat; Serine protease; Signal; Sushi. FT SIGNAL 1..16 FT /evidence="ECO:0000250" FT CHAIN 17..707 FT /note="Complement C1r-A subcomponent" FT /id="PRO_0000027580" FT CHAIN 17..462 FT /note="Complement C1r-A subcomponent heavy chain" FT /evidence="ECO:0000250" FT /id="PRO_0000027581" FT CHAIN 463..707 FT /note="Complement C1r-A subcomponent light chain" FT /evidence="ECO:0000250" FT /id="PRO_0000027582" FT DOMAIN 17..140 FT /note="CUB 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00059" FT DOMAIN 141..189 FT /note="EGF-like; calcium-binding" FT /evidence="ECO:0000255" FT DOMAIN 192..304 FT /note="CUB 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00059" FT DOMAIN 306..372 FT /note="Sushi 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DOMAIN 373..448 FT /note="Sushi 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DOMAIN 463..704 FT /note="Peptidase S1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00274" FT ACT_SITE 501 FT /note="Charge relay system" FT /evidence="ECO:0000250" FT ACT_SITE 559 FT /note="Charge relay system" FT /evidence="ECO:0000250" FT ACT_SITE 656 FT /note="Charge relay system" FT /evidence="ECO:0000250" FT MOD_RES 166 FT /note="(3R)-3-hydroxyasparagine" FT /evidence="ECO:0000250" FT MOD_RES 205 FT /note="Phosphoserine; by CK2" FT /evidence="ECO:0000250|UniProtKB:P00736" FT CARBOHYD 124 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 220 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:17330941" FT CARBOHYD 583 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 70..88 FT /evidence="ECO:0000250" FT DISULFID 145..164 FT /evidence="ECO:0000250" FT DISULFID 160..173 FT /evidence="ECO:0000250" FT DISULFID 175..188 FT /evidence="ECO:0000250" FT DISULFID 192..219 FT /evidence="ECO:0000250" FT DISULFID 249..267 FT /evidence="ECO:0000250" FT DISULFID 308..357 FT /evidence="ECO:0000250" FT DISULFID 337..370 FT /evidence="ECO:0000250" FT DISULFID 375..428 FT /evidence="ECO:0000250" FT DISULFID 405..446 FT /evidence="ECO:0000250" FT DISULFID 450..579 FT /note="Interchain (between heavy and light chains)" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00059, FT ECO:0000255|PROSITE-ProRule:PRU00274, ECO:0000255|PROSITE- FT ProRule:PRU00302" FT DISULFID 622..641 FT /evidence="ECO:0000250" FT DISULFID 652..682 FT /evidence="ECO:0000250" FT CONFLICT 101 FT /note="S -> R (in Ref. 1; AAG01898)" FT /evidence="ECO:0000305" FT CONFLICT 359 FT /note="N -> H (in Ref. 3; AAH04637)" FT /evidence="ECO:0000305" SQ SEQUENCE 707 AA; 80073 MW; 29DAAEB3C047D8E8 CRC64; MWLFALLVTL FYGVEGSIYL PQKLYGEVTS PLYPKPYPSD LETTTVITVP MGYRVKLVFW QFDVEPSEGC FYDYVKISAD KQTLGRFCGQ LDSPLGNPPG SKEFMSQGNK MLLTFHTDFS NEENGTIMFY KGFLAYYQAV DLDECASQPN SVEEGLQPRC QHLCHNYVGG YFCSCHPGYE LQKDGQSCQA ECSSELYTEP SGYVSSLEYP QPYPPDLRCN YSIRVERGLT VHLKFLDPFE IDDHQQVHCP YDQLQIYANG KNLGEFCGKQ RPPDLDTSSN AVDLLFFTDE SGDSRGWKLH YTTETIKCPQ PKALDEFTII QDPQPQYQFR DYFIVTCKQG YQLMEGNQAL LSFTAVCQND GTWHRAMPRC KIKNCGQPQS LSNGDFRYIT TKGVTTYEAS IQYHCHEPYY KMLTRAGSSE SMRGIYTCTA QGIWKNEEEG EKMPRCLPVC GKPVNPVTQK ERIIRGQPAR PGNFPWQAFT TTHGRGGGAL LGDRWILTAA HTIYPKHHNK ENDNANPKML VFLGHTNVEQ IKKLGHHPVR RVIIHPDYRQ DEPNNFEGDI ALLELENSVT LGPELLPICL PDNETFYGQG LMGYVSGFGI TEDKLAFDLR FVRLPVADSE ACQRWLQTKK DTSPFSQNMF CSGDPAVQQD ACQGDSGGVF AVRDRNRDIW VATGIVSWGI GCGEGYGFYT KVLNYVDWIK KEMGDEN //